Spinnaker Trust’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Hold
1,664
0.01% 276
2025
Q4
$204K Buy
+1,664
New +$202K 0.01% 293
2020
Q2
Sell
-2,784
Closed -$208K 239
2020
Q1
$208K Buy
+2,784
New +$192K 0.02% 222
2018
Q2
Sell
-2,831
Closed -$213K 215
2018
Q1
$213K Buy
+2,831
New +$225K 0.02% 204
2016
Q2
Sell
-13,209
Closed -$1.21M 201
2016
Q1
$1.21M Buy
13,209
+230
+2% +$20.7K 0.17% 93
2015
Q4
$1.31M Sell
12,979
-646
-5% -$67.2K 0.19% 85
2015
Q3
$1.34M Sell
13,625
-290
-2% -$32.2K 0.2% 81
2015
Q2
$1.63M Sell
13,915
-531
-4% -$58K 0.24% 74
2015
Q1
$1.42M Sell
14,446
-4,460
-24% -$453K 0.2% 79
2014
Q4
$1.78M Sell
18,906
-326
-2% -$33.7K 0.26% 68
2014
Q3
$2.05M Buy
19,232
+4,915
+34% +$481K 0.33% 60
2014
Q2
$1.19M Sell
14,317
-3,486
-20% -$271K 0.19% 77
2014
Q1
$1.26M Sell
17,803
-7,288
-29% -$572K 0.21% 74
2013
Q4
$1.89M Sell
25,091
-11,343
-31% -$790K 0.31% 67
2013
Q3
$2.29M Buy
36,434
+340
+0.9% +$20.3K 0.41% 57
2013
Q2
$1.85M Buy
+36,094
New +$1.88M 0.35% 64

Other funds holding GILD

Spinnaker Trust's GILD Position: Q1 2026 in Review

Spinnaker Trust held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,664 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #276.

Spinnaker Trust first reported a position in GILD in Q2 2013 and has held it in 16 quarters since. The position peaked at $2.29M in Q3 2013. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Spinnaker Trust held 1,664 shares of Gilead Sciences worth $232K as of Q1 2026.
  • Spinnaker Trust left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.01% of Spinnaker Trust's portfolio in Q1 2026, its #276 holding.
  • Spinnaker Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 16 quarters since.
  • Spinnaker Trust's Gilead Sciences position peaked at $2.29M in Q3 2013.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Spinnaker Trust's 13F filing for Q1 2026, filed 23 Apr 2026.